Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
Anticancer Research|June 29, 2026
Urinary Lipid Profiling for Biomarker Discovery in Clear Cell Renal Cell CarcinomaGaku Ishikawa, Keita Tamura, Kyohei Watanabe, et al.
Urologia Internationalis|September 14, 2011
Clinically significant urethral stricture and/or subclinical urethral stricture after high-intensity focused ultrasound correlates with disease-free survival in patients with localized prostate cancerKazumasa Komura, Teruo Inamoto, Peter C Black, et al.
Nutrition and Cancer|August 2, 2011
Prognostic significance of body mass index in Asian patients with localized renal cell carcinomaKazumasa Komura, Teruo Inamoto, Peter C Black, et al.
Expert Review of Anticancer Therapy|May 23, 2020
Real-world use of sorafenib for advanced renal cell carcinoma patients with cardiovascular disease: nationwide survey in JapanTeruo Inamoto, Haruhito Azuma, Katsunori Tatsugami, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 15, 2011
Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimenHaruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.
International Journal of Clinical Oncology|April 28, 2010
Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinomaKazumasa Komura, Teruo Inamoto, Motomu Tsuji, et al.
Japanese Journal of Clinical Oncology|August 2, 2015
Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?Shigeru Sakano, Teruo Inamoto, Ryo Inoue, et al.
IJU Case Reports|May 8, 2025
Initial Case Report of Robot-Assisted Radical Cystectomy With Intracorporeal Neobladder Using hinotori Surgical Robot SystemHiromitsu Watanabe, Kyohei Watanabe, Yuto Matsushita, et al.
Cancer Investigation|November 21, 2007
Invasive ability of human renal cell carcinoma cell line Caki-2 is accelerated by gamma-aminobutyric acid, via sustained activation of ERK1/2 inducible matrix metalloproteinasesTeruo Inamoto, Haruhito Azuma, Takeshi Sakamoto, et al.
World Journal of Urology|December 17, 2010
Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancerYutaka Fujisue, Haruhito Azuma, Teruo Inamoto, et al.
Pageof 19